Tazicef 1gm Inj , 1vial

Manufacturer HOSPIRA Active Ingredient Ceftazidime(SEF tay zi deem) Pronunciation SEF tay ZYE deem
It is used to treat bacterial infections.
đŸˇī¸
Drug Class
Antibiotic
đŸ§Ŧ
Pharmacologic Class
Third-generation Cephalosporin
🤰
Pregnancy Category
Category B
✅
FDA Approved
Jul 1983
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Ceftazidime is an antibiotic medication used to treat a wide range of bacterial infections, including serious ones like pneumonia, meningitis, and severe skin or urinary tract infections. It works by killing the bacteria that cause these infections.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. Administer the medication as directed, either as an intramuscular injection or as an intravenous infusion over a specified period. In some cases, it may be given as an intravenous push.

Storing and Disposing of Your Medication

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist for guidance on proper storage.

Missing a Dose

If you miss a dose, contact your doctor to determine the best course of action.
💡

Lifestyle & Tips

  • Complete the full course of medication as prescribed, even if you start feeling better, to prevent the infection from returning and to reduce the risk of antibiotic resistance.
  • Do not share this medication with others.
  • Report any new or worsening symptoms to your healthcare provider.
💊

Available Forms & Alternatives

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 1 to 2 grams IV or IM every 8 to 12 hours
Dose Range: 1000 - 6000 mg

Condition-Specific Dosing:

Uncomplicated Urinary Tract Infection: 250 mg IV or IM every 12 hours
Complicated Urinary Tract Infection: 500 mg IV or IM every 8 to 12 hours
Uncomplicated Pneumonia: 500 mg to 1 gram IV or IM every 8 hours
Bone and Joint Infections: 2 grams IV every 12 hours
Severe or Life-Threatening Infections (e.g., Meningitis, Febrile Neutropenia): 2 grams IV every 8 hours
đŸ‘ļ

Pediatric Dosing

Neonatal: 0-4 weeks: 30 mg/kg IV every 12 hours (for meningitis, 50 mg/kg IV every 12 hours)
Infant: 1 month to 12 years: 30 to 50 mg/kg IV every 8 hours (maximum 6 grams/day)
Child: 1 month to 12 years: 30 to 50 mg/kg IV every 8 hours (maximum 6 grams/day)
Adolescent: 12 years and older: Refer to adult dosing (1 to 2 grams IV or IM every 8 to 12 hours)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: CrCl 31-50 mL/min: 1 gram IV/IM every 12 hours
Moderate: CrCl 16-30 mL/min: 1 gram IV/IM every 24 hours
Severe: CrCl 6-15 mL/min: 500 mg IV/IM every 24 hours
Dialysis: CrCl <5 mL/min: 500 mg IV/IM every 48 hours. Administer a loading dose of 1 gram, then 1 gram after each hemodialysis session. Peritoneal dialysis: 500 mg IV/IM every 24 hours.

Hepatic Impairment:

Mild: No adjustment needed
Moderate: No adjustment needed
Severe: No adjustment needed

Pharmacology

đŸ”Ŧ

Mechanism of Action

Ceftazidime is a bactericidal antibiotic that inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs). This inhibits the final transpeptidation step of peptidoglycan synthesis in the bacterial cell wall, leading to inhibition of cell wall biosynthesis and eventually bacterial cell lysis.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (IM administration)
Tmax: IM: 1 hour
FoodEffect: Not applicable (parenteral administration)

Distribution:

Vd: 0.21-0.28 L/kg
ProteinBinding: Approximately 10%
CnssPenetration: Yes (especially with inflamed meninges)

Elimination:

HalfLife: 1.8 to 2 hours (normal renal function)
Clearance: Primarily renal clearance via glomerular filtration
ExcretionRoute: Renal (urine)
Unchanged: Approximately 80-90% excreted unchanged in urine within 24 hours
âąī¸

Pharmacodynamics

OnsetOfAction: Rapid (within minutes of IV administration)
PeakEffect: IV: End of infusion; IM: 1 hour
DurationOfAction: Dependent on dose and renal function, typically allows for 8-12 hour dosing intervals

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of a severe skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis), such as:
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Red or irritated eyes
+ Sores in the mouth, throat, nose, or eyes
Dark urine or yellow skin and eyes
Difficulty urinating or changes in urine output
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak
Redness or white patches in the mouth or throat
Vaginal itching or discharge
Severe diarrhea, which can be a sign of a potentially life-threatening condition called C. diff-associated diarrhea (CDAD)
Stomach pain, cramps, or very loose, watery, or bloody stools (if you experience any of these symptoms, contact your doctor right away)
Seizures, confusion, shakiness, muscle twitching, or difficulty controlling body movements (if you have kidney problems, talk to your doctor, as your dose may need to be adjusted)

Other Possible Side Effects

Most people do not experience severe side effects, and some may not have any side effects at all. However, if you notice any of the following side effects, contact your doctor if they bother you or do not go away:

Diarrhea
Upset stomach or vomiting
Stomach pain
Irritation at the injection site

This is not a comprehensive list of all possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe allergic reaction (hives, difficulty breathing, swelling of your face, lips, tongue, or throat)
  • Severe stomach pain, watery or bloody diarrhea (even if it occurs months after your last dose)
  • Seizures (convulsions)
  • Unusual bleeding or bruising
  • Fever, chills, body aches, flu-like symptoms
  • Pale skin, easy bruising or bleeding
  • Dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you are currently taking chloramphenicol.

This is not an exhaustive list of potential interactions. Therefore, it is crucial to discuss all of your medications (including prescription and over-the-counter drugs, natural products, and vitamins) and health conditions with your doctor and pharmacist. This will help ensure your safety while taking this medication.

To avoid potential interactions, do not start, stop, or modify the dosage of any medication without first consulting your doctor. Your doctor will help you determine whether it is safe to take this medication in conjunction with your other medications and health conditions.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. If you are taking this drug for an extended period, your doctor may recommend regular blood tests to monitor your condition.

If you have diabetes and regularly test your urine for glucose, consult with your doctor to determine the most suitable testing method for you, as this medication may affect the accuracy of certain tests. Additionally, be sure to notify all your healthcare providers and laboratory personnel that you are taking this medication, as it may interfere with the results of some lab tests.

Do not take this medication for longer than prescribed, as this can increase the risk of developing a secondary infection. Older adults (65 years and older) should use this medication with caution, as they may be more susceptible to side effects.

If you are pregnant, planning to become pregnant, or breastfeeding, it is crucial to discuss the potential benefits and risks of this medication with your doctor to ensure the best possible outcome for you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Seizures
  • Encephalopathy (confusion, altered consciousness)
  • Asterixis (flapping tremor)
  • Neuromuscular excitability

What to Do:

Seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222). Hemodialysis may be useful in removing ceftazidime from the body.

Drug Interactions

🔴

Major Interactions

  • Aminoglycosides (e.g., gentamicin, tobramycin): Increased risk of nephrotoxicity and ototoxicity. Monitor renal function closely.
  • Loop Diuretics (e.g., furosemide): May increase the risk of nephrotoxicity when co-administered with cephalosporins, especially in patients with pre-existing renal impairment.
🟡

Moderate Interactions

  • Probenecid: Decreases renal tubular secretion of ceftazidime, leading to increased and prolonged plasma concentrations of ceftazidime. Generally not recommended for co-administration.
  • Oral Contraceptives: Theoretical risk of reduced efficacy due to alteration of gut flora, though clinical significance is low. Advise backup contraception.
  • Warfarin: Cephalosporins may alter vitamin K metabolism or gut flora, potentially enhancing the anticoagulant effect of warfarin. Monitor INR closely.
đŸŸĸ

Minor Interactions

  • Typhoid Vaccine (live, oral): Antibiotics may reduce the therapeutic effect of the live typhoid vaccine. Administer at least 24 hours apart.

Monitoring

đŸ”Ŧ

Baseline Monitoring

Renal function (BUN, serum creatinine)

Rationale: Ceftazidime is primarily renally eliminated; dose adjustment is necessary in renal impairment.

Timing: Prior to initiation of therapy

Culture and Susceptibility testing

Rationale: To confirm the causative organism and its susceptibility to ceftazidime.

Timing: Prior to initiation of therapy

📊

Routine Monitoring

Renal function (BUN, serum creatinine)

Frequency: Periodically, especially in patients with pre-existing renal impairment or those receiving concomitant nephrotoxic drugs.

Target: Within normal limits or stable for patient's baseline

Action Threshold: Significant increase in BUN/creatinine; consider dose adjustment or discontinuation.

Complete Blood Count (CBC) with differential

Frequency: Periodically, especially during prolonged therapy (e.g., >10 days).

Target: Within normal limits

Action Threshold: Significant changes (e.g., eosinophilia, leukopenia, thrombocytopenia); investigate and consider discontinuation.

Liver function tests (ALT, AST, bilirubin)

Frequency: Periodically, if clinically indicated or during prolonged therapy.

Target: Within normal limits

Action Threshold: Significant elevation; investigate.

Signs and symptoms of superinfection (e.g., oral thrush, vaginal candidiasis, new onset diarrhea)

Frequency: Daily throughout therapy and post-therapy.

Target: Absence of new infections

Action Threshold: Presence of new infection; initiate appropriate treatment.

đŸ‘ī¸

Symptom Monitoring

  • Signs of allergic reaction (rash, itching, hives, swelling, difficulty breathing)
  • Gastrointestinal disturbances (nausea, vomiting, diarrhea, abdominal pain)
  • Neurological symptoms (headache, dizziness, seizures, especially in patients with renal impairment or high doses)
  • Signs of Clostridioides difficile-associated diarrhea (CDAD) (severe, persistent diarrhea, abdominal cramps, fever)
  • Injection site reactions (pain, inflammation, phlebitis)

Special Patient Groups

🤰

Pregnancy

Ceftazidime is classified as Pregnancy Category B. Animal reproduction studies have not demonstrated a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if clearly needed.

Trimester-Specific Risks:

First Trimester: No evidence of increased risk of congenital anomalies.
Second Trimester: No specific risks identified.
Third Trimester: No specific risks identified.
🤱

Lactation

Ceftazidime is excreted in human milk in low concentrations. The amount ingested by the infant is small and generally considered compatible with breastfeeding. Monitor the infant for potential changes in bowel flora (e.g., diarrhea, candidiasis) or allergic reactions.

Infant Risk: Low risk (L2)
đŸ‘ļ

Pediatric Use

Ceftazidime has been used safely and effectively in pediatric patients, including neonates. Dosing must be carefully adjusted based on age, weight, and renal function. Neonates and infants may have immature renal function, requiring careful monitoring and dose adjustment.

👴

Geriatric Use

Elderly patients are more likely to have decreased renal function, which necessitates careful dose adjustment based on creatinine clearance. They may also be more susceptible to adverse effects, particularly neurological effects (e.g., seizures) if doses are not appropriately adjusted for renal impairment.

Clinical Information

💎

Clinical Pearls

  • Ceftazidime has excellent activity against Pseudomonas aeruginosa, making it a crucial agent for treating infections caused by this challenging pathogen.
  • It is often used empirically in febrile neutropenia due to its broad-spectrum gram-negative coverage, including Pseudomonas.
  • Always adjust the dose in patients with renal impairment to prevent accumulation and potential neurotoxicity (e.g., seizures).
  • While generally well-tolerated, monitor for C. difficile-associated diarrhea, which can occur during or after therapy.
  • Ceftazidime does not have significant activity against MRSA or enterococci.
🔄

Alternative Therapies

  • Other third-generation cephalosporins (e.g., cefotaxime, ceftriaxone - but generally less active against Pseudomonas)
  • Fourth-generation cephalosporins (e.g., cefepime - good anti-pseudomonal activity)
  • Carbapenems (e.g., meropenem, imipenem/cilastatin, doripenem - broad-spectrum, including Pseudomonas)
  • Aminoglycosides (e.g., tobramycin, amikacin - often used in combination with beta-lactams for severe Pseudomonas infections)
  • Antipseudomonal penicillins (e.g., piperacillin/tazobactam)
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 1g vial per 1g vial
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic), Tier 3 (Brand)
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, avoid flushing medications down the toilet or pouring them down the drain. If you are unsure about the correct disposal method, consult your pharmacist for guidance. Many communities offer drug take-back programs, which your pharmacist can help you locate. Some medications may come with an additional patient information leaflet; check with your pharmacist to see if this applies to your prescription. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken to ensure prompt and effective treatment.